This company seems to have been delisted
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Reason: Acquired by Novo Holdings
Source: https://www.catalent.com/catalent-news/novo-holdings-completes-acquisition-of-catalent/
Catalent
CTLT
$90.82
Share price
0.00%
Change (1 day)
20.27%
Change (1 year)
Categories
Catalent is an American pharmaceutical contract research and development company.
Operating Margin for Catalent (CTLT)
Operating Margin as of March 2025 (TTM): -2.05%
According to Catalent's latest financial reports and stock price the company's current Operating Margin is -2.05%. At the end of 2023 the company had an Operating Margin of -3.66%.
Operating Margin history for Catalent from 2013 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -3.66% | -125.03% |
| 2022 | 14.62% | -29.16% |
| 2021 | 20.64% | 65.4% |
| 2020 | 12.48% | 15.92% |
| 2019 | 10.76% | 0.65% |
| 2018 | 10.69% | -1.68% |
| 2017 | 10.88% | -13.89% |
| 2016 | 12.63% | 6.31% |
| 2015 | 11.88% | -5.8% |
| 2014 | 12.61% | 26.63% |
| 2013 | 9.96% | -16.36% |
| 2012 | 11.91% | 13.92% |
| 2011 | 10.45% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 14.78% | -820.98% | 🇺🇸 USA |
 | -10.86% | 429.76% | 🇺🇸 USA |
 | 11.55% | -663.41% | 🇮🇪 Ireland |
 | -59.02% | 2,779.02% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.